Who owns ASCENDIS PHARMA A/S?
- CUSIP Number: 04351pad3
Tip: Access positions for across all investors
Analyze quarterly positions in Ascendis Pharma A/s with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ascendis Pharma A/s stock
Who bought or sold ASCENDIS PHARMA A/S this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Wolverine Asset Management | 140M | $162M | 0% | Mar 2024 |
|
| Franklin Resources | 47M | $54M | 9% | Mar 2024 |
|
| Readystate Asset Management | 42M | $49M | 62% | Mar 2024 |
|
| Aviva | 26M | $30M | -3% | Mar 2024 |
|
| Citadel Advisors | 26M | $30M | 839% | Mar 2024 |
|
| Point72 Asset Management | 16M | $19M | -6% | Mar 2024 |
|
| Davidson Kempner Capital Management | 15M | $17M | 100% | Mar 2024 |
|
| Zazove Associates | 13M | $15M | -28% | Mar 2024 |
|
| Aequim Alternative Investments | 12M | $13M | 100% | Mar 2024 |
|
| Calamos Advisors | 8.5M | $9.8M | 0% | Mar 2024 |
|
| Capstone Investment Advisors | 5.5M | $6.4M | 0% | Mar 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 5.0M | $5.7M | 0% | Mar 2024 |
|
| BlackRock | 4.6M | $5.3M | 19% | Mar 2024 |
|
| SSI Investment Management | 4.2M | $4.3M | -7% | Dec 2023 |
|
| DAFNA Capital Management | 4.0M | $4.6M | 0% | Mar 2024 |
|
| Nicholas Investments Partners | 3.0M | $3.1M | 0% | Dec 2023 |
|
| CSS | 3.0M | $3.5M | -76% | Mar 2024 |
|
| Wells Fargo & Company | 3.0M | $3.4M | -18% | Mar 2024 |
|
| Credit Suisse | 2.4M | $2.1M | -17% | Mar 2024 |
|
| Man Group | 2.3M | $2.7M | -16% | Mar 2024 |
|
| Royal Bank of Canada | 2.1M | $2.4M | -2% | Mar 2024 |
|
| Bnp Paribas Investment Partners | 2.0M | $2.3M | 100% | Mar 2024 |
|
| Morgan Stanley | 1.8M | $2.0M | -49% | Mar 2024 |
|
| Shenkman Capital Management | 500k | $583M | 100% | Mar 2024 |
|
| Central Pacific Bank - Trust Division | 443k | $511k | 100% | Mar 2024 |
|
| Jane Street | 350k | $402k | -97% | Mar 2024 |
|
| KBC Group NV | 200k | $229k | 0% | Mar 2024 |
|
| First Hawaiian Bank | 173k | $199k | 71% | Mar 2024 |
|
| Boussard & Gavaudan Investment Management | 6.0k | $6.9M | 100% | Mar 2024 |
|
| Context Capital Management | 5.6k | $6.5M | -100% | Mar 2024 |
|
Who sold out of Ascendis Pharma A/s?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Braidwell | Dec 2023 | 127M | $130M |
| D. E. Shaw & Co | Dec 2023 | 23M | $23M |
| Wellington Management Company | Sep 2023 | 19M | $17M |
| American Century Companies | Sep 2023 | 14M | $13M |
| Linden Advisors | Sep 2023 | 8.5M | $7.8B |
| Citigroup | Dec 2023 | 1.1M | $1.1M |
| Virtus Investment Advisers | Dec 2023 | 34k | $35k |